Enzon Pharmaceuticals, Inc. (BST:EZ1)

Germany flag Germany · Delayed Price · Currency is EUR
0.0585
-0.0005 (-0.85%)
At close: Jul 22, 2025
-0.85%
Market Cap5.46M
Revenue (ttm)24.06K
Net Income (ttm)-1.24M
Shares Outn/a
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24
Average Volume64
Open0.0575
Previous Close0.0590
Day's Range0.0575 - 0.0590
52-Week Range0.0485 - 0.2300
Betan/a
RSI40.03
Earnings DateAug 8, 2025

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1981
Employees 1
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol EZ1
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.